£197.47

This is the most expensive it has ever been. Walk away.

£197 today · previous high £197 · all-time low £145

Springer Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 85 days · 85 data points (no recent data)

Historical
Generating forecast…
£197.47 £139.64 £152.26 £164.88 £177.49 £190.11 £202.73 11 August 2026 01 September 2026 22 September 2026 13 October 2026 03 November 2026
View at Amazon ↗

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 85 days • 4 price levels

Days at Price
Current Price
5 days 27 days 9 days 44 days · current 0 11 22 33 44 £145 £151 £167 £197 Days at Price

Price Analysis

Most common price: £197 (44 days, 51.8%)

Price range: £145 - £197

Price levels: 4 different prices over 85 days

Description

Provides a timely overview of critical advances in molecular and cellular neurobiology, covers key methodologies driving progress, and highlights key future directions for research on neuronal injury and neurodegeneration relevant to neuronal brain pathologies. The editors bring together contributions from internationally recognized workers in the field to provide an up to date account of how and why molecular and cellular neurobiology is such an important area for clinical neuroscience. Understanding the molecular aspects of a number of neurodegenerative conditions such as Parkinson's or Alzheimer's disease for the purpose of improving patient management remains a major challenge of neurobiology be it from the basic or clinical perspective. A strategic evaluation of research contributions and the power of modern methods will help advance knowledge over the next years.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
90% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Neurodegenerative Disorders: A Clinical Guide
88% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 23 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
87% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
87% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£144.94 22 Oct 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
86% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£108.06 23 Oct 2026
Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)
86% match

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Springer

£73.80 16 Oct 2026
Molecular Imaging of Neurodegenerative Disorders
86% match

Molecular Imaging of Neurodegenerative Disorders

Springer

£96.81 26 Oct 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
85% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 04 Nov 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
85% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.15 30 Oct 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
85% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 27 Oct 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
85% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£113.03 23 Oct 2026
Pathobiology of Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
84% match

Pathobiology of Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology

Springer

£199.99 24 Aug 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
84% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.28 26 Oct 2026
The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)
84% match

The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)

Springer

£113.67 22 Oct 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
84% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£109.43 23 Oct 2026
Cellular and Molecular Control of Neuronal Migration: 800 (Advances in Experimental Medicine and Biology, 800)
84% match

Cellular and Molecular Control of Neuronal Migration: 800 (Advances in Experimental Medicine and Biology, 800)

Springer

£108.42 22 Oct 2026
Cell Adhesion Molecules: Implications in Neurological Diseases: 8 (Advances in Neurobiology, 8)
84% match

Cell Adhesion Molecules: Implications in Neurological Diseases: 8 (Advances in Neurobiology, 8)

Springer

£106.30 26 Oct 2026
84% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 21 Oct 2026
Cellular and Molecular Methods in Neuroscience Research
84% match

Cellular and Molecular Methods in Neuroscience Research

Springer

£108.01 21 Oct 2026
Models of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
84% match

Models of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Springer

£184.81 26 Aug 2026
CNS Neuroprotection: 155 (Handbook of Experimental Pharmacology, 155)
83% match

CNS Neuroprotection: 155 (Handbook of Experimental Pharmacology, 155)

Springer

£203.62 05 Nov 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
83% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 22 Oct 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
83% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£128.66 05 Nov 2026
RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)
83% match

RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)

Springer

£76.42 30 Aug 2026